Published 2001
| Version v1.0.0
Journal Article
Open
Thrombotic microangiopathy in the cancer patient
Creators
Abstract
Thrombotic microangiopathy, manifesting as thrombotic thrombocytopenic purpura (TTP) or hemolytic uremic syndrome, is a common complication in cancer patients. It shares the pathogenic microvascular occlusive lesion and many clinical manifestations as the classical TTP, but the spectrum of complications varies widely. Several subsets are seen, including a microangiopathic hemolyticanemia in advanced cancer, chemotherapeutic drug-associated microangiopathy and those with the transplant setting. The prognosis is not as favorable as in classical TTP. Anecdotal reports indicate that responses are seen with plasma exchange and with immunoadsorption.Other
original_citation: Kwaan, H. C., & Gordon, L. I. (2001). Thrombotic microangiopathy in the cancer patient. Acta Haematol, 106(1-2), 52-56. https://doi.org/10.1159/000046589Files
cv 293 thromb microangio in CA.pdf
Files
(419.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:36b23f917170f5e2a1c06784b1ff01f3
|
419.9 kB | Preview Download |
Additional details
Identifiers
- PMID
- 11549777
- ARK
- ark:/c8131/g3gg68
Dates
- Created
-
2001When the item was originally created.